Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NovellusDx

NovellusDx
2011 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE (Cancelled)
9 INVESTORS
Description

Developer of gene-profiling platform designed to treat cancerous tumors. The company's gene-profiling platform offers a technology that helps in comprehensive, automated, functional gene profiling of cancer tumors of individual patients, enabling oncology professionals to treat every cancer and each patient with the precise treatment and to support pharmaceutical companies with their drugs life cycle.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Diagnostic Equipment
Primary Office
  • Jerusalem Bio-Park 5th floor
  • Hadassah Medical Center Campus, POB 12057
  • Jerusalem 91120
  • Israel
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NovellusDx’s full profile, request a free trial.

NovellusDx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 17-Dec-2018 Cancelled Generating Revenue
5. Later Stage VC 30-Apr-2018 000 000.00 Completed Clinical Trials - Phase 1
4. Grant 31-Jan-2017 00000 000.00 Completed Clinical Trials - Phase 1
3. Early Stage VC 22-Jun-2016 000.00 000.00 Completed Clinical Trials - Phase 1
2. Seed Round 01-Jan-2014 $1.14M $5.14M Completed Clinical Trials - Phase 1
1. Seed Round 01-Jul-2013 $4M $4M Completed Clinical Trials - Phase 1
To view this company’s complete deal history including valuation and funding, request access »

NovellusDx Competitors (67)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foundation Medicine Corporate Backed or Acquired Cambridge, MA 000 00000 00000000000
00000000 000000000 Venture Capital-Backed Beijing, China 000.00 00000000000 000.00
0000 00000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
00000000 Venture Capital-Backed Austin, TX 000 000.00 00000000000 000.00
00000000 000000 Formerly VC-backed Redwood City, CA 000 00000 00000000 00000
To view this company’s complete list of competitors, request access »

NovellusDx Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bio Capital Impact Other Minority 000 0000 000000 0
Helsinn Investment Fund Corporate Venture Capital Minority 000 0000 000000 0
Windham Venture Partners Venture Capital Minority 000 0000 000000 0
BIRD Foundation Limited Partner 000 0000 000000 0
apica investments group Other Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

NovellusDx Executive Team (8)

Name Title Board
Seat
Contact
Info
Haim Gil-Ad Co-Founder, Chief Executive Officer & Board Member
Yaron Shimon Controller
Mandy Gaziel Director, Quality Management
Michael Vidne Ph.D Chief Commercial Officer
Gabi Tarcic Ph.D Vice President, Research & Development

1 Former Executive

You’re viewing 5 of 8 executives. Get the full list »

NovellusDx Board Members (7)

Name Representing Role Since Contact
Info
Asaf Shinar Pontifax Venture Capital Board Member 000 0000
Charles Woler MD Self President of the Board 000 0000
Erez Chimovits OrbiMed Board Member 000 0000
Haim Gil-Ad NovellusDx Co-Founder, Chief Executive Officer & Board Member 000 0000
Heiner Dreismann NovellusDx Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »